We’d like to offer heartfelt thanks and special recognition of Almac Group, a Club Level Member of the BABCPHL. The global organization has commenced work on supporting eleven separate crucial research projects into COVID-19 treatment options for a variety of global pharmaceutical, biotech and research institutions. Almac is supporting this urgent research need through a range of services across the organization’s business units, including analytical services, peptide development, expedited Interactive Response Technology (IRT) support and clinical trial manufacturing, packaging and distribution. These vital projects cover a range of different areas including vaccines and various potential treatments for symptoms and the effects of this disease.
In addition to this immediate research support, Almac continues to directly contribute to key operations in the supply chain of hundreds of life-saving drugs in a wide variety of therapeutic areas including oncology, neurology, pain management and cardiovascular. The BABCPHL is truly honored to work with Almac Group, a leading life sciences company dedicated to advancing human health and wellbeing. Thank you for helping us fight this global pandemic.
